Co-Diagnostics, Inc. Common Stock (CODX) — Capital Reinvestment Ratio
Co-Diagnostics, Inc. Common Stock (CODX) has a Capital Reinvestment Ratio of 0.21x as of September 2022, meaning it reinvests 0% of its operating cash flow ($1.12 Million) in capital expenditures ($230.05K). Check CODX tangible net assets ratio to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Co-Diagnostics, Inc. Common Stock Capital Reinvestment Ratio (2020–2022)
This chart tracks Co-Diagnostics, Inc. Common Stock's Capital Reinvestment Ratio across 3 annual periods. For the full cash flow conversion analysis, see Co-Diagnostics, Inc. Common Stock (CODX) cash flow conversion.
Annual Capital Reinvestment Ratio for Co-Diagnostics, Inc. Common Stock (2020–2022)
Year-by-year Capital Reinvestment Ratio for Co-Diagnostics, Inc. Common Stock from 2020 to 2022. See how much free cash does Co-Diagnostics, Inc. Common Stock generate to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2022 | 0.22x | $6.57 Million | $1.43 Million | ▲ +1233.6% |
| 2021 | 0.02x | $41.08 Million | $669.46K | ▼ -40.7% |
| 2020 | 0.03x | $28.17 Million | $774.40K | — |